Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Expanded Access Imaging of Neuroendocrine Tumors Using 68Ga-DOTA-TOC

NCT03001349 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03001349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03001349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Expanded Access Imaging of Neuroendocrine Tumors Using 68Ga-DOTA-TOC
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Terminated
Start date
May 16, 2017
Completion date
February 5, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

meningioma, metastatic well differentiated neuroendocrine neoplasm, multiple endocrine neoplasia type 1, neuroendocrine neoplasm, somatostatin positive neoplastic cells present, von hippel-lindau syndrome